X0508 4 2025-02-11 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0001725929 Patel Kinnari C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true See Remarks false Common Stock 2025-02-11 4 A 0 57786 0 A 450181 D Common Stock 5675 I By Spouse Common Stock 104927 I By Adaptive Technology LLC Stock Option (Right to Buy) 9.88 2025-02-11 4 A 0 172214 0 A 2035-02-11 Common Stock 172214 172214 D Represent RSUs that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years. The shares are held indirectly through Adaptive Technology, LLC, a limited liability company that is owned and managed by the reporting person's husband. This option represents a right to purchase a total of 172,214 shares of the Issuer's Common Stock, one-third of which will become fully vested and exercisable on February 11, 2026, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. President, Head of R&D and Chief Operating Officer /s/ Martin Wilson, as attorney-in-fact for Kinnari Patel 2025-02-13